Non-islet cell tumour hypoglycaemia
Hypoglycaemia · Endocrine
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Recurrent fasting hypoglycaemia from tumour secretion of incompletely processed IGF-2 (big IGF-2), typically with large mesenchymal or epithelial tumours.
Red flags
- Severe / recurrent hypoglycaemia
- Reduced conscious level
- Large mediastinal / abdominal tumour
- Seizures
Assessment
Differential diagnosis
- Insulinoma
- Sulfonylurea-induced hypoglycaemia
- Adrenal insufficiency
- Factitious insulin use
- Critical illness / liver failure
Investigations
- Capillary and laboratory glucose
- Insulin, C-peptide, IGF-2:IGF-1 ratio during hypoglycaemia
- Cortisol
- Imaging for underlying tumour
- Sulfonylurea screen
Management
- Treat acute hypoglycaemia immediately
- Confirm true hypoglycaemia with paired samples
- Distinguish from insulinoma (low insulin/C-peptide here)
- Search for and treat the underlying tumour
- Prevent recurrence with frequent feeds / glucose support
- Endocrinology and oncology referral
Drugs & doses
IV glucose for acute episodes
Corticosteroids or glucagon (specialist, to raise glucose)
Directed tumour therapy
Disposition
Admit; endocrinology + oncology.
Complications & pitfalls
- Neuroglycopenic injury
- Recurrent hypoglycaemia
- Complications of the underlying tumour
Exam pearls
- Low insulin and C-peptide with hypoglycaemia point away from insulinoma.
- Tumour resection can cure the hypoglycaemia.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.